Free tool
FAERS Monitor: Dextrose 5% and Sodium Chloride 0.45% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017607 or its brand name (Dextrose 5% and Sodium Chloride 0.45% In Plastic Container, Dextrose, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
167
Serious
157
94% of reports
Hospitalization
109
Death reported
58
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- vomiting40
- nausea34
- hyponatraemia28
- sepsis28
- ascites27
- constipation27
- abdominal distension26
- abdominal pain26
- off label use26
- general physical health deterioration25
- anaemia24
- appendicitis24
- appendicolith24
- cardiogenic shock24
- ventricular fibrillation24
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 14 |
| 2016 | 9 |
| 2017 | 6 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 12 |
| 2021 | 12 |
| 2022 | 25 |
| 2023 | 20 |
| 2024 | 23 |
| 2025 | 7 |
| 2026 | 10 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,992 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| appendicolithSignal | 24 | 8335.3 | 5676.1 | 179,864 |
| appendicitisSignal | 24 | 324.4 | 223.9 | 7,402 |
| ventricular fibrillationSignal | 24 | 272.7 | 188.2 | 6,218 |
| cardiogenic shockSignal | 24 | 211.0 | 145.6 | 4,803 |
| ascitesSignal | 27 | 115.8 | 81.9 | 2,960 |
| hyponatraemiaSignal | 28 | 62.6 | 44.7 | 1,641 |
| sepsisSignal | 28 | 31.6 | 22.6 | 804 |
| abdominal distensionSignal | 26 | 31.4 | 22.0 | 738 |
| general physical health deteriorationSignal | 25 | 27.2 | 19.0 | 609 |
| anaemiaSignal | 24 | 15.9 | 10.9 | 322 |
| constipationSignal | 27 | 15.6 | 11.0 | 358 |
| abdominal painSignal | 26 | 14.1 | 9.9 | 306 |
| vomitingSignal | 40 | 10.7 | 8.2 | 351 |
| nauseaSignal | 34 | 5.4 | 4.0 | 122 |
| off label useSignal | 26 | 3.7 | 2.6 | 52 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.